Seer says it received rival buyout proposals at $2.55 and $2.45 a share

The biotech company said its board’s Special Committee will review the unsolicited offers from the Radoff-JEC Group and Chair and Chief Executive Officer Omid Farokhzad, M.D., alongside other alternatives.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.